Apogee Biotechnology
Business Services · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1214 Research Blvd Ste 2015, Hummelstown...Phone Number
(717) 531-4758Website
www.apogee-biotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Apogee Biotechnology
Apogee Biotechnology Corporation, founded in 2001 and based in Hershey, Pennsylvania, focuses on developing orally available small molecules for cancer and inflammatory disease treatments. The company is dedicated to advancing its sphingosine kinase inhibitor program, particularly targeting solid tumors and chronic inflammatory diseases. Their product pipeline includes the clinical lead compound ABC294640 (opaganib), which has shown efficacy in various cancers and inflammatory conditions, as well as in COVID-19 patients. Apogee is privately held and primarily funded through grants, including those from the NIH and the Pennsylvania Department of Health.Explore more
Popular SearchesApogee Biotechnology CorpApogee BiotechnologyApogee Biotechnology isSIC Code 87,873NAICS Code 54,541Show moreApogee Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Apogee Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Apogee Biotechnology launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Apogee Biotechnology has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Apogee Biotechnology is spiking on competitors!
Earning: See what the market has to say on Apogee Biotechnology recently announced quarterly report
Check if Apogee Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Apogee Biotechnology
Apogee Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Apogee Biotechnology had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Apogee Biotechnology as Masked Content
Find 3 more new buyers
Compare Similar Companies to Apogee Biotechnology
Compare insights from companies similar to Apogee Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Apogee Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Apogee Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Apogee Biotechnology.
Apogee Biotechnology financials insights
Gather financial insights about Apogee Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$67K
Apogee Biotechnology Tech Stack
A closer look at the technologies used by Apogee Biotechnology
See more technologies
Apogee Biotechnology News & Media
RedHill Biopharma Announces Initiation of Phase IIa Study with ABC294640 (YELIVA®) for Cholangiocarcinoma at Mayo Clinic and MD Anderson
TEL-AVIV, Israel and RALEIGH, N.C., Dec. 22, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal diseases and cancer, today announced the initiation of a Phase IIa study with YELIVA® (ABC294640)1 for the treatment of cholangiocarcinoma.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Apogee Biotechnology
Sign Up For FreeTo access detailed company insights
Apogee Biotechnology Corporation, founded in 2001 and based in Hershey, Pennsylvania, focuses on developing orally available small molecules for cancer and inflammatory disease treatments. The company is dedicated to advancing its sphingosine kinase inhibitor program, particularly targeting solid tumors and chronic inflammatory diseases. Their prod... Read More
